This is the authors' abstract. We don't add key points for this paper.
Germ-free mice had increased frailty, lower muscle mass, and lower circulating inflammatory monocytes. Therefore, lower systemic inflammation coincided with worse frailty and muscle loss. Microbial colonization decreased frailty, restored muscle mass, and increased circulating inflammatory monocytes while lowering transcripts in inflammatory TNF and NF-κB pathways within muscle. Hence, microbiota can increase circulating inflammation but decrease muscle inflammation to protect against frailty. This microbiota-muscle axis should be investigated for therapeutic potential in muscle wasting and sarcopenia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Conn et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: